AdvisorShares Investments LLC boosted its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 82.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,394 shares of the specialty pharmaceutical company’s stock after acquiring an additional 12,869 shares during the [...]
Earnings americanbankingnews May 30, 2026